Medically reviewed by Dale Garber, MDJuvenile myositis (JM) affects those under the age of 18 years. JM is known for causing ...

Childhood-specific biomarker discovery is ongoing for many rheumatic diseases, including lupus nephritis, systemic JIA and macrophage activation syndrome, Kawasaki disease, dermatomyositis and ...

Treatment with dazukibart, a monoclonal antibody targeting interferon beta, yielded a rapid reduction in dermatomyositis disease activity in adults with skin-predominant and muscle-predominant ...